Ours Privacy Scores $15M Series A Round
Ours PrivacyCompany
LightbankInvestor
Health Velocity CapitalInvestor
Rock HealthInvestor
Lakehouse ResortInvestor
TMVInvestor
Switch VenturesInvestor
GreyMatterInvestor
Ours Privacy raised $15 million in a Series A round on Aug. 21, 2026, led by Lightbank and Health Velocity Capital, with participation from Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures, GreyMatter and others, to accelerate its HIPAA‑compliant customer data platform for healthcare marketers.
Deal Terms
Ours Privacy closed a $15 million Series A financing on Aug. 21, 2026. The round was led by Lightbank and Health Velocity Capital and was described as multiple‑times‑oversubscribed. Existing backers Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures, GreyMatter and additional investors also participated. The capital will be deployed to expand the go‑to‑market engine, deepen product engineering, and broaden integrations with advertising, EHR and scheduling ecosystems.
Background
Founded to address the unique privacy constraints of the healthcare sector, Ours Privacy offers a customer data platform (CDP) built by marketers for marketers. The solution is HIPAA‑compliant and connects to major channels—including Google Ads, Meta Ads, demand‑side platforms, electronic health‑record systems, scheduling tools and data warehouses—allowing health systems, digital‑health firms and national medical brands to orchestrate campaigns without exposing protected health information. The company positions itself as the only growth‑marketing infrastructure purpose‑built for the regulatory rigor of healthcare advertising.
The Series A arrives as health‑tech marketers grapple with tightening data‑privacy rules and the need for unified, compliant audience activation. By securing a dedicated growth‑capital infusion, Ours Privacy aims to accelerate feature development, add sales capacity, and pursue partnerships that embed its platform deeper into the tech stacks of large health providers.
The financing underscores investor confidence in a niche SaaS model that couples compliance with performance‑marketing capabilities. Lightbank and Health Velocity Capital cited the platform’s early traction with leading health systems and its potential to become a de‑facto standard for privacy‑first campaign orchestration. Details on valuation or revenue multiples were not disclosed.
Why It Matters
The new capital gives Ours Privacy the runway to outpace rivals such as Salesforce Health Cloud and Adobe Experience Platform, which offer broader marketing suites but lack native HIPAA compliance. By expanding its integration catalog and sales force, Ours Privacy can lock in larger health‑system contracts before competitors retrofit compliance features. Existing customers gain faster access to advanced segmentation and attribution tools, strengthening retention and opening upsell pathways.
For investors, the round validates a growing appetite for vertical SaaS solutions that solve regulatory friction points. The influx of capital may pressure other privacy‑focused health‑tech startups to demonstrate comparable product depth or risk being sidelined in a market where compliance is a non‑negotiable entry barrier.
Key Points
- Ours Privacy secured $15 million in a Series A round led by Lightbank and Health Velocity Capital
- The round was multiple‑times‑oversubscribed and included Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures, GreyMatter and others
- Funding will be used to scale sales, product development and integrations for the HIPAA‑compliant CDP
- Ours Privacy targets healthcare marketers, positioning itself as the only growth‑marketing platform built for HIPAA compliance
Analysis
While the exact valuation was not disclosed, a $15 million Series A for a compliance‑centric SaaS platform typically implies a multiple in the high‑single‑digit to low‑double‑digit range of ARR, reflecting both the niche market and the capital intensity of building secure integrations. The health‑tech sector is witnessing a surge in privacy‑first infrastructure as regulators tighten data‑use rules, creating a defensible moat for platforms that embed compliance at the core. Investors such as Lightbank and Health Velocity Capital are betting that Ours Privacy can capture a sizable share of the $10‑plus billion spend on healthcare marketing technology, where many incumbents still rely on generic, non‑HIPAA‑ready stacks.
For operators, the raise signals that vertical SaaS models that solve a regulatory pain point can attract sizable early‑stage capital even without disclosed revenue metrics. The funding will likely accelerate product road‑maps, enabling deeper API connections with ad networks and EHRs, and support a national sales push. For the broader SaaS investor community, the deal reinforces the premium placed on compliance as a growth lever, suggesting that future rounds in health‑tech may increasingly favor companies that combine data‑driven marketing capabilities with built‑in privacy safeguards.